![Mark Collins](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Collins
Directeur/Membre du Conseil chez
LUNAI BIOWORKS INC.
Fortune : 18 748 $ au 30/09/2026
Profil
Dr. Mark A. Collins is an Independent Director at Lunai Bioworks, Inc. and a Chief Scientific Officer at Undaunted Bio, Inc. He is on the Board of Directors at Lunai Bioworks, Inc. Dr. Collins was previously employed as a Chief Technology Officer by Helomics Corp.
and a Vice President-Translational Service by icometrix NV.
He received his undergraduate degree from the University of Wolverhampton and a doctorate degree from the University of Surrey.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
LUNAI BIOWORKS, INC. 0,25 % | 13/10/2026 | 12 754 ( 0,25 % ) | 18 748 $ | 30/09/2026 |
Postes actifs de Mark Collins
| Sociétés | Poste | Début |
|---|---|---|
| LUNAI BIOWORKS INC. | Directeur/Membre du Conseil | 14/10/2024 |
Anciens postes connus de Mark Collins
| Sociétés | Poste | Fin |
|---|---|---|
Helomics Corp.
 Helomics Corp. Miscellaneous Commercial ServicesCommercial Services Provides cancer care development and treatment consulting services | Directeur Technique/Scientifique/R&D | 01/01/2021 |
icometrix NV
 icometrix NV Packaged SoftwareTechnology Services Provides AI-powered brain imaging analysis for neurological disorders | Corporate Officer/Principal | 01/01/2021 |
Formation de Mark Collins
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
13
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Lunai Bioworks, Inc.
 Lunai Bioworks, Inc. BiotechnologyHealth Technology Operates as preclinical stage biotechnology company developing technologies and therapies for HIV, HBV and cancer | Health Technology |
Helomics Corp.
Helomics Corp. Miscellaneous Commercial ServicesCommercial Services Provides cancer care development and treatment consulting services | Commercial Services |
University of Wolverhampton
 University of Wolverhampton Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Surrey
 University of Surrey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
icometrix NV
icometrix NV Packaged SoftwareTechnology Services Provides AI-powered brain imaging analysis for neurological disorders | Technology Services |
